AAAAAA

   
Results: 1-7 |
Results: 7
EPIRUBICIN AS A SINGLE-AGENT IN COMPARISON TO CMF IN ADJUVANT THERAPYOF STAGE-I AND STAGE-II BREAST-CANCER
Authors: COLOZZA M BISAGNI G MOSCONI AM GORI C BONI C BIAN AR SABBATINI R FRASSOLDATI A PASSALACQUA R RODINO C RONDINI E ALGERI R DISARRA S BACCHI M TONATO M COCCONI G
Citation: M. Colozza et al., EPIRUBICIN AS A SINGLE-AGENT IN COMPARISON TO CMF IN ADJUVANT THERAPYOF STAGE-I AND STAGE-II BREAST-CANCER, European journal of cancer, 34, 1998, pp. 86-86
BILATERAL GLENOID HYPOPLASIA
Authors: BELUFFI G FIORI P RODINO C
Citation: G. Beluffi et al., BILATERAL GLENOID HYPOPLASIA, European radiology, 8(6), 1998, pp. 986-988
INTRAPANCREATIC LIPOMA - FIRST CASE DIAGNOSED WITH CT
Authors: DIMAGGIO EM SOLCIA M DORE R PREDA L LAFIANZA A RODINO C CAMPANI R
Citation: Em. Dimaggio et al., INTRAPANCREATIC LIPOMA - FIRST CASE DIAGNOSED WITH CT, American journal of roentgenology, 167(1), 1996, pp. 56-57
THE COMBINATION OF CISPLATIN, DOXORUBICIN, AND MITOMYCIN (PAM) COMPARED WITH THE FAM REGIMEN IN TREATING ADVANCED GASTRIC-CARCINOMA - A PHASE-II RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH
Authors: DELISI V COCCONI G ANGELINI F CAVICCHI F DICOSTANZO F GILLI G RODINO C SOLDANI M TONATO M FINARDI C
Citation: V. Delisi et al., THE COMBINATION OF CISPLATIN, DOXORUBICIN, AND MITOMYCIN (PAM) COMPARED WITH THE FAM REGIMEN IN TREATING ADVANCED GASTRIC-CARCINOMA - A PHASE-II RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH, Cancer, 77(2), 1996, pp. 245-250
HYDROXYUREA (HU), HIGH-DOSE FOLINIC ACID (L-FA) AND 5FU VS HU, 5FU AND INTERFERON-ALFA-2B (IFN) IN ADVANCED COLORECTAL-CANCER (ACRC) - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC)
Authors: DICOSTANZO F SDROBOLINI A MARZOLA S ZIRONI S CONTU A PUCCI E RODINO C CORGNA E ALGERI R BISAGNI G ANGIONA S
Citation: F. Dicostanzo et al., HYDROXYUREA (HU), HIGH-DOSE FOLINIC ACID (L-FA) AND 5FU VS HU, 5FU AND INTERFERON-ALFA-2B (IFN) IN ADVANCED COLORECTAL-CANCER (ACRC) - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC), European journal of cancer, 31A, 1995, pp. 721-721
CISPLATIN AND VP16 IN METASTATIC BREAST-CARCINOMA AS A 3RD-LINE CHEMOTHERAPY - A RANDOMIZED STUDY COMPARING LOW VERSUS HIGH-DOSES OF CISPLATIN
Authors: CECI G BISAGNI G COCCONI G RODINO C BELSANTI V BERTUSI M BUZZI F BACCHI M
Citation: G. Ceci et al., CISPLATIN AND VP16 IN METASTATIC BREAST-CARCINOMA AS A 3RD-LINE CHEMOTHERAPY - A RANDOMIZED STUDY COMPARING LOW VERSUS HIGH-DOSES OF CISPLATIN, Tumori, 81(4), 1995, pp. 241-244
FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN COMBINATION VERSUS PELF CHEMOTHERAPY IN ADVANCED GASTRIC-CANCER - A PROSPECTIVE RANDOMIZED TRIAL OF THE ITALIAN-ONCOLOGY-GROUP-FOR-CLINICAL-RESEARCH
Authors: COCCONI G BELLA M ZIRONI S ALGERI R DICOSTANZO F DELISI V LUPPI G MAZZOCCHI B RODINO C SOLDANI M GILLI G FINARDI C
Citation: G. Cocconi et al., FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN COMBINATION VERSUS PELF CHEMOTHERAPY IN ADVANCED GASTRIC-CANCER - A PROSPECTIVE RANDOMIZED TRIAL OF THE ITALIAN-ONCOLOGY-GROUP-FOR-CLINICAL-RESEARCH, Journal of clinical oncology, 12(12), 1994, pp. 2687-2693
Risultati: 1-7 |